Dr. Frank Richard

Dr. Frank Richard

Vice President Medical, AI and Machine Learning, Oncology Drug Development Heidelberg Pharma AG

Frank Richard is VP Medical at Heidelberg Pharma AG with over 20 years of R&D experience. He leads clinical trials for cancer treatment using ADCs and enhances dose prediction through data modeling. His expertise spans immune-oncology, respiratory and rare diseases. He holds an MD, MBA, and is a board-certified Clinical Pharmacologist. He also brings unique insights into Bayesian Statistics and machine learning.

1. Conference Day, 02. September 2025

9:50 Panel: Digitalization and AI in Clinical Trials

-Opportunities and Challenges – How are digital technologies and AI changing the efficiency, quality, and ethics of clinical trials?

-Automation and Data Analytics – What role does AI play in patient recruitment, data analysis, and decision-making?

-Future Perspectives – How can regulatory frameworks and technological innovations further advance the development of clinical trials?

-Human vs. Machine – How does the human factor remain relevant and crucial in an increasingly AI-driven research environment?

14:20 AI in clinical trials - when innovation meets feasibility

  • AI in Pharma & Biotech 
  • Use cases & solutions 
  • Challenges & Lessons Learned 

Check out the incredible speaker line-up to see who will be joining Frank.

Download The Latest Agenda